from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1288/-

LFCtreatmentdescriptionclass of inhibitor

-0.406

Amikacinug/mL Amikacintranslation

1.252

Cap5-10ug/mL Capreomycintranslation

2.895

Rox10-50 ug/mL Roxithromycintranslation

0.804

SM2-5 ug/mL Streptomycintranslation

1.128

Tet5-10 ug/mL Tetracyclinetranslation

-0.899

Rif0.2-5ug/mL Rifampicintranscription

0.459

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.015

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.360

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.609

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.728

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.220

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

4.554

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.087

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.066

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.412

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.493

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.467

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.569

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.368

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

1.081

KCN5-20 ug/mL Potassium cyaniderespiration

0.077

NaN30.2-2 mM Sodium aziderespiration

0.731

Nigericin50 uM Nigericinrespiration

-0.948

TRC10-150 ug/mL Triclosanrespiration

0.853

TRZ10-25 ug/mL Thioridazinerespiration

-1.093

Valinomycin0.5-10 uM Valinomycinrespiration

0.047

ZnSO42 mM ZnSO4respiration

-0.635

menadione6-10 ug/mL Menadionerespiration

-0.983

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.236

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.888

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.321

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.600

NRP_1Non-replicating persistence stage 1dosRassociated

-0.219

Amp0.2mg/mL AmpicillincellWall

-0.267

Cephalexin20-100 ug/mL CephalexincellWall

-0.174

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.307

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.276

EMB10-20 ug/mL EthambutolcellWall

-0.723

Eta12-40 ug/mL EthionamidecellWall

-0.560

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.623

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.336

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.220

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.048

BZA0.12 mg/mL BenzamidearomaticAmides

-0.078

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

1.019

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

1.055

H2O24 mM hydrogen peroxideDNAdamaging

-0.374

Levo10 ug/mL LevofloxacinDNAdamaging

-0.192

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

1.440

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.459

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.209

UVUV-irradiationDNAdamaging

1.109

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.382

Antimycin12.5-50 ug/mL Antimycin A?

0.066

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.248

PA_110-50 ug/mL Antitubercular compound PA-1?

0.243

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.301

PA8240.2-2 ug/mL PA-824?

-0.272

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.191

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.339

Verapamil50 uM Verapamil?

0.422

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.018

methoxatin10-20 ug/mL Methoxatin?